Common variants at 11p13 are associated with susceptibility to tuberculosis
Thorsten Thye(University Hospital Schleswig-Holstein), Christian G. Meyer(Bernhard Nocht Institute for Tropical Medicine), Sergey Nejentsev(University of Cambridge), John O. Gyapong(Ghana Health Service), Edhyana Sahiratmadja(Padjadjaran University), Fredrik Vannberg(Centre for Human Genetics), Jürgen Sievertsen(Bernhard Nocht Institute for Tropical Medicine), Vladyslav Nikolayevskyy(Queen Mary University of London), Christa Ehmen(Bernhard Nocht Institute for Tropical Medicine), Reinout van Crevel(Radboud University Nijmegen), Giorgio Sirugo(Medical Research Council), Birgit Muntau(Bernhard Nocht Institute for Tropical Medicine), Yanina Balabanova(Queen Mary University of London), Adrian V. S. Hill(Jenner Institute), Bachti Alisjahbana(Dr. Hasan Sadikin General Hospital), Philip C. Hill(MRC Unit the Gambia), Esther van de Vosse(Leiden University Medical Center), Gerd Ruge(Bernhard Nocht Institute for Tropical Medicine), James Curtis(University of Cambridge), Ellis Owusu‐Dabo(Kwame Nkrumah University of Science and Technology), Francis Drobniewski(Imperial College London), Melanie J. Newport(Brighton and Sussex Medical School), Rolf D. Horstmann(Bernhard Nocht Institute for Tropical Medicine), Tom H. M. Ottenhoff(Office of Infectious Diseases)
Cited by 220
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
|Nature Genetics|2007|1.5k
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
|New England Journal of Medicine|1996|878
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
|Nature Medicine|2020|643
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591